SCWorx Corp(WORX) Price Forecast & Company Analysis. P/E · Dividend · Earnings · Price Target · RSI · MACD | US Stocks Today
Oct 13 at 4:52 PM ET (Korea 10/14 05:52)
Full metrics table
| Index | - | P/E | - | EPS (ttm) | -39.65 | Insider Own | 5.03% | Shs Outstand | 0.6M | Perf Week | -66.07% |
| Market Cap | 0.00B | Forward P/E | - | EPS next Y | - | Insider Trans | - | Shs Float | 0.5M | Perf Month | -18% |
| Enterprise Value | 0.00B | PEG | - | EPS next Q | - | Inst Own | 0.03% | Short Float | 1.73% | Perf Quarter | -71% |
| Income | -0.00B | P/S | 0.46 | EPS this Y | - | Inst Trans | - | Short Ratio | 0.14 | Perf Half Y | -81.53% |
| Sales | 0.00B | P/B | 0.03 | EPS next 5Y | - | ROA | -32.83% | Short Interest | 0.01M | Perf YTD | -92.61% |
| Book/sh | 77.66 | P/C | 1.08 | EPS past 3/5Y | 35.86% 45.11% | ROE | -38.06% | 52W High | -97.92% ($118.19) | Perf Year | -95.03% |
| Cash/sh | 2.29 | P/FCF | - | Sales past 3/5Y | -10.68% -11.21% | ROIC | -33.99% | 52W Low | 6.96% ($2.30) | Perf 3Y | -99.34% |
| Dividend Est. | - | EV/EBITDA | - | EPS Y/Y TTM | 79.64% | Gross Margin | 25.67% | Volatility(W/M) | 35.65% 18.28% | Perf 5Y | -99.96% |
| Dividend TTM | - | EV/Sales | 0.03 | Sales Y/Y TTM | 3.07% | Oper. Margin | -20.1% | ATR (14) | 1 | Perf 10Y | -100% |
| Dividend Ex-Date | - | Quick Ratio | 2.19 | EPS Q/Q | 98.35% | Profit Margin | -80.54% | RSI (14) | 40.33 | Recom | - |
| Dividend Gr. 3/5Y | - | Current Ratio | 2.19 | Sales Q/Q | 3.43% | SMA20 | -32.76% ($3.66) | Beta | 1.38 | Target Price | - |
| Payout | - | Debt/Eq | 0 | Earnings | - | SMA50 | -48.93% ($4.82) | Rel Volume | 107.27 | Prev Close | $3.16 |
| Employees | 9 | LT Debt/Eq | 0 | EPS/Sales Surpr. | - | SMA200 | -86.9% ($18.78) | Avg Volume(3M) | 0.07M | Price | $2.46 |
| IPO | 2016/10/6 | Option/Short | No/No | Trades | 47578 | Volume | 7,113,649 | Change | -22.15% |
🏥 SCWorx (WORX) is a healthcare information technology company that specializes in standardizing supply chain master data—such as pharmaceuticals, medical devices, and consumables—for major U.S. hospitals and medical institutions, and offers healthcare asset procurement cost-reduction solutions through its proprietary AI-based platform.
Over the past 1 year, on the lower side
98% below its 1-year high.
Traded more than usual. That is 10727% of its average volume.
WORX has a sound balance sheet but weak earning power
Of every $100 in sales, $20.10 is lost.
Tap to view numbers
Relative to sales, it looks cheap
Loss-making, so we compare on sales. For a company selling $100 a year, you would pay $46. Peers typically go for $85.
Tap to view numbers
Holding long would have lost money
Bought 5 years ago, your return today would be -100.0%. The S&P 500 did +79% over the same period.
Tap to view numbers
No dividend
There is no profit to distribute yet.
Institutions barely hold it
Institutions hold 0.0%.
Tap to view numbers
It ranks #42 of 42 in the industry
Based on market cap of $1M.
FAQ
What kind of company is WORX?
WORX belongs to the Healthcare sector and operates in the Health Information Services industry.
What is the market cap of WORX?
The market cap of WORX is approximately $1M, ranking 5,860 within its sector.
What is the 52-week high and low for WORX?
WORX has recorded a 52-week high of $118.19 and a low of $2.30.
